{
    "clinical_study": {
        "@rank": "36792", 
        "arm_group": {
            "arm_group_label": "Celecox group"
        }, 
        "brief_summary": {
            "textblock": "This study is to assess the safety and efficacy of celecoxib on the pain relief from acute\n      pain."
        }, 
        "brief_title": "Celecoxib Japan Observational Study for the Patients With Acute Pain", 
        "completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "condition": "Patients With Traumatic Pain, Post-surgical Pain and Tooth Extract Pain", 
        "detailed_description": {
            "textblock": "Patients with traumatic pain, post-surgical and tooth extract pain will be included in this\n      study.  Patients will receive Celecoxib for 2 weeks and the efficacy on pain relief and the\n      safety will be evaluated."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with traumatic pain, post-surgical pain and tooth extract pain\n\n        Exclusion Criteria:\n\n          -  Hyperreactive to sulfonamide\n\n          -  Aspirin asthma patients\n\n          -  Peptidic ulcer patients\n\n          -  Serious liver disease patients\n\n          -  Serious kidney disease patients\n\n          -  Serious heart failure patients\n\n          -  End of pregnancy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with traumatic pain, post-surgical pain and tooth extract pain"
            }
        }, 
        "enrollment": {
            "#text": "784", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01876121", 
            "org_study_id": "COX-05"
        }, 
        "intervention": {
            "arm_group_label": "Celecox group", 
            "description": "oral", 
            "intervention_name": "Celecoxib", 
            "intervention_type": "Drug", 
            "other_name": "Celecox"
        }, 
        "intervention_browse": {
            "mesh_term": "Celecoxib"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "NSAIDs", 
            "Acute pain"
        ], 
        "lastchanged_date": "June 11, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Chubu", 
                        "country": "Japan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hokkaido", 
                        "country": "Japan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kansai", 
                        "country": "Japan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kantou", 
                        "country": "Japan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Kyushu", 
                        "country": "Japan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Shikoku", 
                        "country": "Japan"
                    }
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Touhoku", 
                        "country": "Japan"
                    }
                }
            }
        ], 
        "location_countries": {
            "country": "Japan"
        }, 
        "number_of_groups": "1", 
        "official_title": "Celecoxib Japan Observational Study for the Patients With Acute Pain", 
        "overall_official": {
            "affiliation": "Astellas Pharma Inc", 
            "last_name": "Use Central Contact", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Japan: Pharmaceuticals and Medical Devices Agency", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Safety assessed by the incidence of adverse events and lab-tests", 
            "safety_issue": "No", 
            "time_frame": "For 2 weeks"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01876121"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Overall pain improvement assessed by visual analogue scale (VAS)", 
            "safety_issue": "No", 
            "time_frame": "Baseline and week-2"
        }, 
        "source": "Astellas Pharma Inc", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Astellas Pharma Inc", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "July 2012", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}